全文获取类型
收费全文 | 15965篇 |
免费 | 1651篇 |
国内免费 | 2013篇 |
专业分类
19629篇 |
出版年
2024年 | 69篇 |
2023年 | 270篇 |
2022年 | 543篇 |
2021年 | 862篇 |
2020年 | 626篇 |
2019年 | 798篇 |
2018年 | 663篇 |
2017年 | 542篇 |
2016年 | 709篇 |
2015年 | 1046篇 |
2014年 | 1226篇 |
2013年 | 1270篇 |
2012年 | 1503篇 |
2011年 | 1378篇 |
2010年 | 890篇 |
2009年 | 800篇 |
2008年 | 916篇 |
2007年 | 810篇 |
2006年 | 743篇 |
2005年 | 659篇 |
2004年 | 591篇 |
2003年 | 600篇 |
2002年 | 515篇 |
2001年 | 298篇 |
2000年 | 247篇 |
1999年 | 191篇 |
1998年 | 123篇 |
1997年 | 106篇 |
1996年 | 94篇 |
1995年 | 63篇 |
1994年 | 97篇 |
1993年 | 53篇 |
1992年 | 54篇 |
1991年 | 39篇 |
1990年 | 40篇 |
1989年 | 33篇 |
1988年 | 30篇 |
1987年 | 22篇 |
1986年 | 18篇 |
1985年 | 32篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1982年 | 15篇 |
1981年 | 3篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1973年 | 2篇 |
1971年 | 2篇 |
1961年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 7 毫秒
61.
62.
Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. 总被引:10,自引:4,他引:6 下载免费PDF全文
J Rucker A L Edinger M Sharron M Samson B Lee J F Berson Y Yi B Margulies R G Collman B J Doranz M Parmentier R W Doms 《Journal of virology》1997,71(12):8999-9007
Human immunodeficiency virus type 1 (HIV-1) requires both CD4 and a coreceptor to infect cells. Macrophage-tropic (M-tropic) HIV-1 strains utilize the chemokine receptor CCR5 in conjunction with CD4 to infect cells, while T-cell-tropic (T-tropic) strains generally utilize CXCR4 as a coreceptor. Some viruses can use both CCR5 and CXCR4 for virus entry (i.e., are dual-tropic), while other chemokine receptors can be used by a subset of virus strains. Due to the genetic diversity of HIV-1, HIV-2, and simian immunodeficiency virus (SIV) and the potential for chemokine receptors other than CCR5 or CXCR4 to influence viral pathogenesis, we tested a panel of 28 HIV-1, HIV-2, and SIV envelope (Env) proteins for the ability to utilize chemokine receptors, orphan receptors, and herpesvirus-encoded chemokine receptor homologs by membrane fusion and virus infection assays. While all Env proteins used either CCR5 or CXCR4 or both, several also used CCR3. Use of CCR3 was strongly dependent on its surface expression levels, with a larger number of viral Env proteins being able to utilize this coreceptor at the higher levels of surface expression. ChemR1, an orphan receptor recently shown to bind the CC chemokine I309 (and therefore renamed CCR8), was expressed in monocyte and lymphocyte cell populations and functioned as a coreceptor for diverse HIV-1, HIV-2, and SIV Env proteins. Use of ChemR1/CCR8 by SIV strains was dependent in part on V3 loop sequences. The orphan receptor V28 supported Env-mediated cell-cell fusion by four T- or dual-tropic HIV-1 and HIV-2 strains. Three additional orphan receptors failed to function for any of the 28 Env proteins tested. Likewise, five of six seven-transmembrane-domain receptors encoded by herpesviruses did not support Env-mediated membrane fusion. However, the chemokine receptor US28, encoded by cytomegalovirus, did support inefficient infection by two HIV-1 strains. These findings indicate that additional chemokine receptors can function as HIV and SIV coreceptors and that surface expression levels can strongly influence coreceptor use. 相似文献
63.
Hepatitis C virus (HCV) has two envelope proteins, E1 and E2, which form a heterooligomer. During dissection of interacting regions of HCV E1 and E2, we found the presence of an interfering compound or compounds in skim milk. Here we report that human as well as bovine lactoferrin, a multifunctional immunomodulator, binds two HCV envelope proteins. As determined by far-Western blotting, the bacterially expressed E1 and E2 could bind lactoferrin in human milk directly separated or immunopurified and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The bindings of lactoferrin and HCV envelope proteins in vitro were confirmed by another method, the pull-down assay, with immunoprecipitated lactoferrin-bound protein A resin. By the same assay, mammal-expressed recombinant E1 and E2 were also demonstrated to bind human lactoferrin efficiently in vitro. Direct interaction between E2 and lactoferrin was proved in vivo, since anti-human lactoferrin antibody efficiently coimmunoprecipitated with secreted and intracellular forms of the E2 protein, but not glutathione S-transferase (GST), from lysates of HepG2 cells transiently cotransfected with the expression plasmids of human lactoferrin and gE2t-GST (the N-terminal two-thirds of E2 fused to GST) or GST. The N-terminal loop of lactoferrin, the region important for the antibacterial activity, has only a little role in the binding ability to HCV E2 but affected the secretion or stability of lactoferrin. Taken together, these results indicate the specific interaction between lactoferrin and HCV envelope proteins in vivo and in vitro. 相似文献
64.
四个籼稻(Oryza sativa L.)品种幼苗经1℃黑暗或光照250 μm ol·m - 2·s- 1处理后,抗冷的“桂山矮选3”比不抗冷的“青华6 号”幼苗存活率高,其子代是以“桂山矮选3”为母本的比“青华6 号”为母本的存活率较高。抽穗期剑叶经光照低温处理12、24 和36 h 后,光合作用是“桂山矮选3”和以“桂山矮选3”为母本的子代比“青华6 号”和以“青华6 号”为母本的子代下降较少。呼吸作用是前者比后者在处理12 h 时有明显升高现象。荧光参数Fv/Fo和Fv/Fm比值在处理24 h 时前者比后者下降明显,但在常温下恢复则是前者比后者明显较快。自然低温(寒露风)对叶绿素荧光的影响亦有相似的规律。对水稻后代的抗冷性倾向于母本进行了讨论 相似文献
65.
66.
蛇毒抗肝癌作用的研究 总被引:1,自引:0,他引:1
眼镜蛇毒具有抗肝癌作用.我们采用多种小鼠移植性肝癌研究了眼镜蛇毒抗肝癌作用.通过多项指标的体内实验证实眼镜蛇毒经腹腔给药,对小鼠腹水型肝癌 H_(22)(HepA)均有明显的抑制作用,其生存时间,癌重生长抑制率接近5-Fu.我们认为眼镜蛇毒是一种新型的,有一定抗癌活性药物,有在临床上进一步研究的价值. 相似文献
67.
本文根据吴征镒教授对中国种子植物属分市区类型研究结果,研制出定量化研究区域性种子植物区系的电子计算机程序,应用本程序可完成某区系的分布区类型统计分析,科属组成分析和与其它地区以共有属关系构建的相似性系数的谁知盘中计算,同时可大量节省研究人员的劳动强度和时间,对提高研究水平有一定的效果。 相似文献
68.
建立了一种改良的血清1,25-双羟胆钙化醇(1,25-Dihydroxycholecalciferol,DHCC)超微量放射受体检测(RRA)技术。完成了灵敏度、精密度、准确度、稳定性及特异性等技术指标。报告了我国健康青年血清DHCC正常值;检测了先天性佝偻病、青春期佝偻病病人及患肾性骨病奶牛等血清DHCC水平。 根据配体与受体相互结合的定量关系,建立了DHCCR(DHCC受体)检测技术。在游离与结合配基分离方面,除建立与比较了DCC(葡聚糖包埋的活性炭)及HAP(羟基磷灰石)方法外,还首次将IEF(等电聚焦电泳)应用于DHCCR分离技术。对佝偻病鸡小肠粘膜上皮细胞受体含量进行了检测并比较了鸡小肠、输卵管壳腺及肝组织DHCCR含量。 相似文献
69.
本文通过酸性紫色土和石灰性紫色土中不同浓度Cd、Cu、Pb、As对水稻根系脱氢酶的影响研究,揭示了脱氢酶受抑制与产生抗性的过程。在低浓度时,土壤Cd、Cu、Pb、As对脱氢酶的影响较敏感,能因元素的不同性质反映土壤类型影响的差别。最后,以脱氢酶受抑制与初始抗性峰出现的转折点相应的土壤浓度为依据,确定了两种紫色土Cd、Cu、Pb、As的临界浓度。 相似文献
70.
The prevalence of Id and anti-Id T and B cells as measured by their reactivities with two human mAb, one antiacetylcholine receptor mAb and one anti-Id mAb, was studied in 38 patients with myasthenia gravis and in 27 healthy individuals. Id and anti-Id T cells were estimated by enumerating the numbers of cells secreting IFN-gamma in response to 10 pg/ml of the human mAb. T cell stimulation, measured as numbers of IFN-gamma-secreting cells that exceeded the mean + 2 SD of controls, was induced by the Id mAb in 78.9% of the patients and in 7.4% of the controls, whereas the anti-Id mAb-stimulated T cells in 55.3% of the patients and in 3.7% of the controls. The mean value of the Id and anti-Id-reactive T cells in the patients was 18.3/10(5) and 10.1/10(5) PBMC, respectively. B cells secreting IgM antibodies binding to the human mAb were increased in patients with myasthenia gravis compared to healthy controls. Seventy-five percent of the patients and 12% of the controls had B cells secreting IgM antibodies binding to the Id mAb, although 89% of the patients and 16% of the controls had B cells secreting IgM antibodies binding to the anti-Id mAb. The mean value of B cells secreting IgM antibodies binding to Id or anti-Id mAb in the patients were 7.4 cells/10(6) and 5.5 cells/10(6) PBMC, respectively. We conclude that Id and anti-Id T and B cells are present in myasthenia gravis. These methods allow a quantitative estimation of T and B cells with defined specificities and thus a way of mapping the repertoire of lymphocytes. 相似文献